The Effect of Kinesio Taping Application for Dysmenorrhea

NCT02663050 | Unknown

• 1 other identifier: Mustafa
• Study Type: interventional
• Target: 150
• Locations: 0 countries
• Sites: N/A

Brief Summary

Dysmenorrhea is a common symptom in daily practice of gynecology. Different kind of treatment strategies are being held. But invasive and pharmacological therapies have good outcome with systemic side effects. Kinesio taping is being widely used in different pain conditions. Kinesio taping is a noninvasive and nonpharmacological, easy-to-use intervention method which can be used in outpatient practice without systemic side effects.

Conditions

Dysmenorrhea

Keywords

Dysmenorrhea; kinesio tape

Outcome Measures

Primary Outcomes (1)

• Visual analog scale

  At the begining of the Dysmenorrhea before taping we will measure the VAS level (pretreatment)and 4 days after taping we will measure the second VAS level (after treatment)

  0- 4th day

Study Arms (3)

Kinesio taping group

EXPERIMENTAL

only Kinesio taping treatment group

Other: Kinesio taping

NSAID treatment group

ACTIVE COMPARATOR

only NSAIDs taking group

Drug: NSAID's

Combination treatment group

ACTIVE COMPARATOR

NSAIDs plus Kinesio taping group

Other: Kinesio taping; Drug: NSAID's

Interventions

Kinesio taping OTHER

Patients will be taped for four days , ıt will start at the begining of the Dysmenorrhea

Combination treatment group; Kinesio taping group

NSAID's DRUG

twice a daily

Also known as: Diclophenac Potassium

Combination treatment group; NSAID treatment group

Eligibility Criteria

• Age: 18 Years - 40 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Dysmenorrhea

You may not qualify if:

• pregnancy
• surgical abdominal emergency
• metabolic or inflammatory illnesses or cardiovascular diseases,
• endocrine disorders such as diabetes, thyroid disorders, androgen excess (hyperprolactinemia, uncontrolled thyroid disease, congenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumor),
• smokers
• using pharmaceutical agents such as anti-inflammatory agents that could possibly impact on endocrine and liver enzymes
• musculoskeletal pain
• inguinal hernia

Sponsors & Collaborators

• Saglik Bilimleri Universitesi Gulhane Tip Fakultesi: lead

MeSH Terms

Conditions

Dysmenorrhea

Interventions

Diclofenac

Condition Hierarchy (Ancestors)

Menstruation Disturbances; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pelvic Pain; Pain; Neurologic Manifestations; Signs and Symptoms

Intervention Hierarchy (Ancestors)

Phenylacetates; Acids, Carbocyclic; Carboxylic Acids; Organic Chemicals

Study Officials

• Mustafa Öztürk, M.D.

  Etimesgut Military Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Mustafa Öztürk, M.D.

CONTACT

+905358333956; drmozturk@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: M.D.,Obstetrics and Gynecology, Specialist

Study Record Dates

• First Submitted: January 19, 2016
• First Posted: January 26, 2016
• Study Start: February 1, 2016
• Primary Completion: March 1, 2016
• Study Completion: April 1, 2016
• Last Updated: February 29, 2016

Record last verified: 2016-02

Data Sharing

• IPD Sharing: Will share